Internet Sales of "Research Grade Compounds": The Opioid SR-17018 (SR-17) as an Example

{"Several":[0],"internet":[1],"sites":[2],"promote":[3],"the":[4,10,24,44,66,94,102,110,125,128,152,191],"sale":[5],"of":[6,19,79,98,105,124,154,169,190,209],"\\"research":[7,138,196],"grade":[8,139,197],"compounds.\\"Although":[9],"purchaser":[11],"attests":[12],"that":[13,23,35,136,194],"they":[14,21,36],"are":[15,46,144],"over":[16],"18":[17],"years":[18],"age,":[20],"know":[22],"substances":[25],"have":[26],"not":[27,38],"been":[28],"approved":[29],"by":[30],"regulatory":[31],"agencies":[32],"and":[33,205,211],"promise":[34],"will":[37],"use":[39,56],"them":[40],"for":[41,54,60,113,161],"human":[42,61,114,156,207],"consumption,":[43],"compounds":[45],"supplied":[47],"in":[48,201],"tablet":[49],"form,":[50],"which":[51,179],"is":[52,65],"inconvenient":[53],"research":[55,121],"but":[57],"very":[58],"convenient":[59],"consumption.One":[62],"such":[63,141,170],"compound":[64,172],"opioid":[67,96],"SR-17018":[68,143,185],"(aka":[69],"\\"SR-17\\").SR-17018":[70],"was":[71],"originally":[72],"synthesized":[73],"at":[74],"Scripps":[75],"Research":[76],"as":[77,142,146,186],"part":[78],"a":[80,86,120,159,171,187,195,220],"discovery":[81],"effort":[82],"to":[83,180],"test":[84],"whether":[85],"G-protein-'biased'":[87],"mu-opioid":[88],"receptor":[89],"(MOR)":[90],"agonist":[91],"could":[92],"separate":[93],"undesirable":[95],"effect":[97,104],"respiratory":[99],"depression":[100],"from":[101],"desirable":[103],"analgesia.It":[106],"never":[107],"progressed":[108],"through":[109],"stages":[111],"necessary":[112],"clinical":[115,192],"trials,":[116],"so":[117],"it":[118,212],"remained":[119],"\\"tool\\"":[122],"drug.Regardless":[123],"initial":[126],"intent,":[127],"United":[129],"States":[130],"Drug":[131],"Enforcement":[132],"Agency":[133],"(DEA)":[134],"alerts":[135],"some":[137],"compounds\\"":[140],"emerging":[145],"recreational":[147],"or":[148],"abused":[149],"substances.If":[150],"so,":[151],"absence":[153],"adequate":[155,175],"data":[157],"creates":[158],"problem":[160],"healthcare":[162],"providers":[163],"who":[164],"may":[165],"encounter":[166],"an":[167,174,214],"overdose":[168],"without":[173],"evidence":[176],"base":[177],"upon":[178],"draw.This":[181],"narrative":[182],"review":[183],"presents":[184,213],"case":[188],"study":[189],"uncertainty":[193],"compound\\"":[198],"introduces.It":[199],"synthesizes":[200],"vitro,":[202],"ex":[203],"vivo,":[204],"plausible":[206],"pharmacology":[208],"SR-17018,":[210],"emergency":[215],"department":[216],"physician's":[217],"experience":[218],"with":[219],"suspected":[221],"SR-17":[222],"overdose.":[223]}

Authors

Institutions

Publication Details

Journal
Cureus
Published
2026-09-16
DOI
https://doi.org/10.7759/cureus.116383
Primary Topic
Eicosanoids and Hypertension Pharmacology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Internet Sales of "Research Grade Compounds": The Opioid SR-17018 (SR-17) as an Example

Joseph V. Pergolizzi, Eugene Vortsman, Robert B Raffa
Cureus
Eicosanoids and Hypertension Pharmacology
article

Internet Sales of "Research Grade Compounds": The Opioid SR-17018 (SR-17) as an Example

Joseph V. Pergolizzi, Eugene Vortsman, Robert B Raffa
article en

Abstract

Several internet sites promote the sale of "research grade compounds."Although the purchaser attests that they are over 18 years of age, they know that the substances have not been approved by regulatory agencies and promise that they will not use them for human consumption, the compounds are supplied in tablet form, which is inconvenient for research use but very convenient for human consumption.One such compound is the opioid SR-17018 (aka "SR-17").SR-17018 was originally synthesized at Scripps Research as part of a discovery effort to test whether a G-protein-'biased' mu-opioid receptor (MOR) agonist could separate the undesirable opioid effect of respiratory depression from the desirable effect of analgesia.It never progressed through the stages necessary for human clinical trials, so it remained a research "tool" drug.Regardless of the initial intent, the United States Drug Enforcement Agency (DEA) alerts that some "research grade compounds" such as SR-17018 are emerging as recreational or abused substances.If so, the absence of adequate human data creates a problem for healthcare providers who may encounter an overdose of such a compound without an adequate evidence base upon which to draw.This narrative review presents SR-17018 as a case study of the clinical uncertainty that a "research grade compound" introduces.It synthesizes in vitro, ex vivo, and plausible human pharmacology of SR-17018, and it presents an emergency department physician's experience with a suspected SR-17 overdose.

Cureus
Northwell Health (US), North Shore Diabetes and Endocrine Associates (US), Nema Research (United States) (US), Temple University (US)
Openalex Percentile: Top 16%
Eicosanoids and Hypertension Pharmacology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.